CDH16 and neuroendocrine neoplasm: The most commonly CDH16 positive cancers included renal cell carcinomas, nephrogenic adenomas, and follicular neoplasms of the thyroid, followed by tumors of the female genital tract and various categories of neuroendocrine tumors.